Full Text View
Tabular View
No Study Results Posted
Related Studies
Sirolimus in Treating Patients With Angiomyolipoma of the Kidney
This study is ongoing, but not recruiting participants.
Study NCT00126672   Information provided by National Cancer Institute (NCI)
First Received: August 2, 2005   Last Updated: November 1, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Precancerous/Nonmalignant Condition
Additional conditions recognized in this trial
Angiomyolipoma
Precancerous Conditions
More general conditions related to this trial
Neoplasms
Neoplasms by Histologic Type
Neoplasms, Adipose Tissue
Neoplasms, Connective and Soft Tissue
Interventions listed in this trial
sirolimus
More general drug interventions related to this trial
Anti-Bacterial Agents
Anti-Infective Agents
Antibiotics, Antineoplastic
Antifungal Agents
Antineoplastic Agents
Immunologic Factors
Immunosuppressive Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Dana-Farber Cancer Institute
National Cancer Institute (NCI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services